High-fiber diet linked to reduced risk of heart disease in night shift workers
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in… read more.
People who work at night have a higher risk of coronary artery disease, a type of heart disease. A new study suggests that a higher fibre intake in… read more.
Food insecurity can increase anxiety and undermine employees at work, but workplace programs to address it can improve job outcomes, according to research published by the American Psychological… read more.
A study of over 50,000 pregnant women in Norway during the 2023/24 influenza season found that only 29.9% were vaccinated against influenza and 12.1% against COVID-19 during pregnancy, remaining… read more.
A universal respiratory syncytial virus (RSV) immunization program using Beyfortus (nirsevimab) was associated with a statistically significant reduction in RSV-related hospitalizations in the second RSV season among infants… read more.
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day… read more.
Sequel Med Tech, LLC, a company developing transformative drug delivery technologies, and Senseonics Holdings, Inc., a medical technology company focused on long-term, implantable Continuous Glucose Monitoring (CGM) systems… read more.
A global atlas mapping two key gut bacteria in infants around the world has uncovered a treasure trove of bacterial strains adapted to the infant gut and not… read more.
Vir Biotechnology announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, Pro -xten dual-masked T-cell engager (TCE) being evaluated in… read more.
Researchers report that patients diagnosed with cancer who subsequently develop a mental disorder are at an increased risk of all-cause death. The findings were published on Feb. 23,… read more.
Iovance Biotherapeutics Inc. announced data demonstrating a best-in-class profile for commercial Amtagvi (lifileucel) with unprecedented response rates in a real-world clinical, retrospective study in patients with advanced (unresectable… read more.
Researchers at Pompeu Fabra University (UPF) have made a great leap towards predicting the risk of hip fracture among people with osteoporosis and evaluating the effectiveness of specific… read more.
A new study from Adelaide University is turning a spotlight on those tablet versions, finding that the absorption-enhancing ingredient salcaprozate sodium (SNAC) may have measurable adverse biological effects for the gut and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.